Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial

被引：0
|
作者：
Aung Myat
Simon R. Redwood
Satpal Arri
Bernard J. Gersh
Deepak L. Bhatt
Michael S. Marber
机构：
[1] St Thomas’ Hospital,King’s College London British Heart Foundation Centre of Research Excellence, The Rayne Institute, Cardiovascular Division
[2] Frimley Park Hospital,Department of Cardiovascular Medicine
[3] Frimley Health NHS Foundation Trust,undefined
[4] Mayo Clinic College of Medicine,undefined
[5] Brigham and Women’s Hospital Heart & Vascular Centre and Harvard Medical School,undefined
来源：
Diabetology & Metabolic Syndrome | / 13卷
关键词：
Liraglutide; Glucagon-like peptide-1 receptor agonist; Myocardial ischaemia; Chronic stable angina; Coronary artery disease; Incretin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial
    Rassaf, Tienush
    Rammos, Christos
    Hendgen-Cotta, Ulrike B.
    Heiss, Christian
    Kleophas, Werner
    De Hanna, Frank
    Floege, Juergen
    Hetzel, Gerd R.
    Kelm, Malte
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (01): : 108 - 118
  • [22] Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
    Hang, Yuanxing
    Qin, Xian
    Ren, Tianli
    Cao, Jianing
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [23] Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
    Yuanxing Hang
    Xian Qin
    Tianli Ren
    Jianing Cao
    Lipids in Health and Disease, 17
  • [24] Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study
    Lengsfeld, Sophia
    Probst, Leila
    Emara, Yara
    Werlen, Laura
    Vogt, Deborah R.
    Bathelt, Cemile
    Baur, Fabienne
    Caviezel, Brida
    Vukajlovic, Tanja
    Fischer, Manuel
    Winzeler, Bettina
    EBIOMEDICINE, 2024, 107
  • [25] Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial
    Korsatko, Stefan
    Jensen, Lene
    Brunner, Martina
    Sach-Friedl, Stefanie
    Tarp, Maja D.
    Holst, Anders G.
    Heller, Simon R.
    Pieber, Thomas R.
    DIABETES OBESITY & METABOLISM, 2018, 20 (11) : 2565 - 2573
  • [26] Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study
    Kargar, Mona
    Yousefi, Abolghasem
    Mojtahedzadeh, Mojtaba
    Akhondzadeh, Shahin
    Artounian, Valentin
    Abdollahi, Alireza
    Ahmadvand, Alireza
    Ghaeli, Padideh
    SWISS MEDICAL WEEKLY, 2014, 144
  • [27] Vitamin D Treatment Attenuates Heart Apoptosis After Coronary Artery Bypass Surgery: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
    Tasdighi, Erfan
    Hekmat, Manouchehr
    Beheshti, Mahmoud
    Baghaei, Ramin
    Mirhosseini, Seyed Mohsen
    Torbati, Peyman
    Pourmotahari, Fatemeh
    Foroughi, Mahnoosh
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (04) : 338 - 345
  • [28] Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
    Norbert J. Tripolt
    Felix Aberer
    Regina Riedl
    Jasmin Url
    Gudrun Dimsity
    Andreas Meinitzer
    Tatjana Stojakovic
    Faisal Aziz
    Ronald Hödl
    Gabriele Brachtl
    Dirk Strunk
    Marianne Brodmann
    Franz Hafner
    Harald Sourij
    Cardiovascular Diabetology, 17
  • [29] A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia
    Henderson, D. C.
    Fan, X.
    Sharma, B.
    Copeland, P. M.
    Borba, C. P.
    Boxill, R.
    Freudenreich, O.
    Cather, C.
    Evins, A. Eden
    Goff, D. C.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 119 (06) : 457 - 465
  • [30] A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0 mg for weight recurrence after Roux-en-Y gastric bypass
    Lofton, Holly F.
    Maranga, Gabrielle
    Hold, Robert
    Fielding, George
    Youn, Heekoung
    Gujral, Akash
    Heffron, Sean
    Fielding, Christine
    SURGERY FOR OBESITY AND RELATED DISEASES, 2025, 21 (02) : 135 - 145
12345